+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mirabegron Drugs Market - Global Forecast 2025-2030- Product Image
Mirabegron Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Mirabegron Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131146
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Mirabegron market is undergoing rapid transformation as pharmaceutical stakeholders adapt to evolving therapies, regulatory frameworks, and digital innovations. Senior leaders must align strategy with changing patient expectations, competition, and value-based contracting to drive performance and sustained access across diverse healthcare environments.

Market Snapshot: Trends and Growth Trajectory

The Mirabegron market is characterized by steady CAGR and growing uptake for overactive bladder treatment, as this beta3-adrenoceptor agonist offers a distinctive alternative to traditional antimuscarinics. Increased recognition of its favorable tolerability profile is driving broader integration within therapeutic regimens. While originator products maintain clinical leadership, ongoing patent expiries enable generics to reshape competition. External pressures from 2025 US tariffs and dynamic supply chain environments are also influencing cost structures. The interplay of regulatory evolution, clinical data, and patient-centric innovations is fostering substantial opportunities for market participants.

Scope & Segmentation of the Mirabegron Market

This report examines the multifaceted Mirabegron environment across product, dosage, channel, indication, user, and regional axes, offering in-depth analysis to optimize strategic positioning.

  • Product Types: Branded and generic options, each influencing prescription dynamics and lifecycle management.
  • Dosage Forms: Extended release and conventional tablets, balancing adherence and cost sensitivity.
  • Dosage Strengths: 25 mg and 50 mg, each informing titration and efficacy protocols.
  • Distribution Channels: Including hospital pharmacy (government, private), online pharmacy (mobile app, website), and retail pharmacy (chain, independent), reflecting varying procurement and patient engagement models.
  • Indications: Idiopathic and neurogenic overactive bladder, impacting therapeutic positioning.
  • Age Groups: Adult, geriatric, and pediatric populations, with specific prescribing and compliance considerations.
  • End Users: Clinic, home care, and hospital settings influencing patient support and care pathways.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, United Arab Emirates, South Africa, and more), and Asia-Pacific (feature countries such as China, India, Japan, Australia, South Korea, and others).
  • Leading Companies: Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Limited, Aurobindo Pharma Limited, Glenmark Pharmaceuticals Limited.

Key Takeaways for Senior Stakeholders

  • Mirabegron's unique beta3-adrenoceptor agonist mechanism addresses unmet needs in overactive bladder care, supporting a shift toward therapies with enhanced patient adherence.
  • Regulatory progression, including revised labeling and expedited approvals, is shortening time-to-market for innovative formulations and enabling flexible clinical trial collaborations across multiple markets.
  • Broader adoption of digital health solutions—such as remote patient monitoring and adherence-tracking tools—are increasingly integrated into care pathways, amplifying engagement and supporting value-based contracts.
  • Shifting segmentation, including expanded age group and indication focus, empowers manufacturers to target high-potential and underserved segments through tailored product offerings and delivery models.
  • Intensified industry competition is catalyzing strategic alliances, supply chain diversification, and local manufacturing investments to maintain market position post-patent expiry.

Tariff Impact on Mirabegron Supply Chains and Pricing

The introduction of 2025 United States tariffs is prompting price adjustments throughout the Mirabegron value chain. Suppliers and manufacturers are reassessing sourcing strategies, leading to renewed interest in nearshoring and regional production hubs. These moves are enhancing resilience but also intensifying cost and tender management complexities in institutional segments. Advanced analytics and scenario planning tools are supporting organizations as they adapt procurement and margin preservation strategies to mitigate ongoing trade policy risks.

Methodology & Data Sources

This report utilizes a rigorous approach, combining primary interviews with industry experts, regulatory authorities, and supply chain leaders, alongside comprehensive secondary research of filings, literature, and proprietary data sets. Analytical frameworks such as SWOT, Porter’s Five Forces, and segmentation models provide structured insight, while data triangulation and stakeholder workshops ensure validity and balance throughout.

Why This Report Matters

  • Enables decision-makers to identify actionable growth and risk mitigation strategies tailored to rapidly evolving regional and therapeutic settings.
  • Supplies evidence-based benchmarks for portfolio optimization, pricing, and digital health investment within the Mirabegron competitive landscape.

Conclusion

Mirabegron market stakeholders face ongoing challenges and opportunities as technology, regulation, and competition evolve. Leveraging data-driven insights and adaptive planning is crucial for long-term market leadership and patient-focused success.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of mirabegron combination therapies targeting overactive bladder with improved tolerability profiles
5.2. Rising interest in once-daily mirabegron extended-release formulations for patient compliance
5.3. Surging R&D investments in mirabegron analogs for potential extended indications beyond OAB
5.4. Emerging safety data influencing mirabegron prescribing practices in elderly patient populations
5.5. Impact of generic mirabegron market entry on pricing strategies and brand market share dynamics
5.6. Development of pediatric dosage guidelines for mirabegron driven by recent clinical trial outcomes
5.7. Adoption of mirabegron as first-line therapy in multidisciplinary OAB management protocols
5.8. Influence of real-world evidence on mirabegron safety profile and insurance reimbursement policies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mirabegron Drugs Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Mirabegron Drugs Market, by Dosage Form
9.1. Introduction
9.2. Extended Release Tablet
9.3. Tablet
10. Mirabegron Drugs Market, by Dosage Strength
10.1. Introduction
10.2. 25 Mg
10.3. 50 Mg
11. Mirabegron Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Government Hospital
11.2.2. Private Hospital
11.3. Online Pharmacy
11.3.1. Mobile App Pharmacy
11.3.2. Website Pharmacy
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Mirabegron Drugs Market, by Indication
12.1. Introduction
12.2. Idiopathic
12.3. Neurogenic
13. Mirabegron Drugs Market, by Age Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Mirabegron Drugs Market, by End User
14.1. Introduction
14.2. Clinic
14.3. Home Care
14.4. Hospital
15. Americas Mirabegron Drugs Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Mirabegron Drugs Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Mirabegron Drugs Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Astellas Pharma Inc.
18.3.2. Teva Pharmaceutical Industries Ltd.
18.3.3. Viatris Inc.
18.3.4. Sandoz International GmbH
18.3.5. Sun Pharmaceutical Industries Ltd.
18.3.6. Cipla Ltd.
18.3.7. Lupin Limited
18.3.8. Cadila Healthcare Limited
18.3.9. Aurobindo Pharma Limited
18.3.10. Glenmark Pharmaceuticals Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MIRABEGRON DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MIRABEGRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MIRABEGRON DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MIRABEGRON DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. MIRABEGRON DRUGS MARKET: RESEARCHAI
FIGURE 30. MIRABEGRON DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 31. MIRABEGRON DRUGS MARKET: RESEARCHCONTACTS
FIGURE 32. MIRABEGRON DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MIRABEGRON DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MIRABEGRON DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MIRABEGRON DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY EXTENDED RELEASE TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY EXTENDED RELEASE TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY 25 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY 25 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY MOBILE APP PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY MOBILE APP PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY WEBSITE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY WEBSITE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY IDIOPATHIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY IDIOPATHIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY NEUROGENIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY NEUROGENIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MIRABEGRON DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 122. CANADA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 123. CANADA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 124. CANADA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 125. CANADA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. CANADA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. CANADA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. CANADA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. CANADA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. CANADA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. CANADA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. CANADA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. CANADA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 266. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 267. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. FRANCE MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. ITALY MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. ITALY MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. ITALY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 304. ITALY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 305. ITALY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. ITALY MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. ITALY MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. ITALY MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. ITALY MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. ITALY MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. ITALY MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. ITALY MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. ITALY MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. ITALY MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. ITALY MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. ITALY MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. ITALY MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. ITALY MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. ITALY MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. ITALY MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 326. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 327. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 330. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 331. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 332. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 333. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 334. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 335. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 338. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 339. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. SPAIN MIRABEGRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 345. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 346. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES MIRABEGRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mirabegron Drugs market report include:
  • Astellas Pharma Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Lupin Limited
  • Cadila Healthcare Limited
  • Aurobindo Pharma Limited
  • Glenmark Pharmaceuticals Limited

Related Topics

Related Reports

Mirabegron Sustained-release Tablets Market - Global Forecast 2025-2030 - Product Image

Mirabegron Sustained-release Tablets Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Overactive Bladder Treatment Market Report and Forecast 2025-2034 - Product Image

Overactive Bladder Treatment Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Urinary Incontinence Drugs Market Report and Forecast 2025-2034 - Product Image

Urinary Incontinence Drugs Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Overactive Bladder Treatment Market - Global Forecast 2025-2030 - Product Image

Overactive Bladder Treatment Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.